BGF Ventures
Edit

BGF Ventures

https://www.bgf.co.uk
Last activity: 31.03.2025
Active
Invests in categories: ServiceBusinessTechnologyProductITManagementSoftwareCareDesignData
BGF is the most active and influential investor in small and mid-sized businesses in the UK.

An established and independent company, it has £2.5bn to support a range of growing companies – early stage, growth stage and quoted – across every region and sector of the economy.

BGF is a minority, non-controlling equity partner with a patient outlook, based on shared long-term goals with the management teams it backs. With a 150+ strong team, BGF offers an unparalleled international network of business leaders, sector experts, board-level non-executives and provides in-house support with Chair and senior executive selection and appointments.
News
913
Portfolio
396
Persons
67
Mentions
332
Location: United Kingdom, England, Westminster
Employees: 51-200
Founded date: 2011
Investment Stage: Pre-Seed; Seed; Series A; Series B; Series C; Series D

Portfolio 396

DateNameWebsiteTotal RaisedLocation
20.01.2024BSE Groupbusinesssupportexperts.co.uk--
20.01.2024invenioLSIinveniolsi.com-United Kin...
20.01.2024Hyblehyble.tech$3.55MUnited Kin...
18.11.2023ViaNautisvianautis.com$25M-
09.11.2023Purplepurple.ai$10.94MUnited Kin...
25.10.2023Primary Ca...primarycarephysio.co.uk-United Kin...
25.10.2023Kooth Digi...koothplc.com-United Kin...
25.10.2023The Avoca ...avocaclinic.ie-Ireland, T...
25.10.2023Artus Airartusair.com-United Kin...
25.10.2023Stellar Om...stellaruk.co.uk$5.49MUnited Kin...
Show more

Persons 67

DateFirst NameLast NameTitleLinkedInLocation
-LouiseHaworthFront of H...linkedin.c... ...
-FenPengelleyExecutive ...-
-HollyParryExecutive ...-
-AndreaTryfonExecutive ...linkedin.c...-
-AlishaBissoondoy...Investor&a...linkedin.c...-
-ElaineMcCollExecutive ...linkedin.c...-
-JoeHigginsInvestor&a...linkedin.c...-
-SharonWatsonExecutive ...-
-PaulOldhamPortfolio ...linkedin.c...-
-EdwinDaviesInvestor&a...linkedin.c...-
Show more

News 913

DateTitleDescription
18.11.2023BGF calls for a new British ISA to drive Britain’s long-term growthBGF has today become a lead signatory of an open letter advocating for a new creative approach to reforming ISAs at next week’s Autumn Statement, via a new British ISA or “BRISA”. By giving taxpayers the chance to invest their full £20,000...
18.11.2023ViaNautis raises £20 million Series A financing to drive the next generation of genetic nanomedicinesViaNautis Bio, a ground-breaking nanomedicine company at the forefront of genetic therapies, has completed its Series A funding round, raising £20 million. Formerly known as SomaServe, ViaNautis has secured support from a consortium of pro...
10.11.2023Gujarati Diwali and New Year’s celebrationsPratish Patel joined BGF’s Portfolio Finance team in Birmingham in 2017. Here, Pratish shares the history of Diwali and how he celebrates the festival with his family each year. Diwali is one of the biggest and most important celebrations ...
09.11.2023BGF’s Head of Operations: What Remembrance Day means to meAs our Head of Operations, Leigh Edgar is responsible for the business support operations across all of BGF’s offices in the UK and Ireland. Here, Leigh shares his connection to Remembrance Day, and how you can show support this November. ...
09.11.2023Victorian Sliders targets ‘world-class’ status after new £4 million BGF investmentSouth Wales manufacturing company Victorian Sliders is being tipped to become a ‘world-class’ business, following a new £4 million investment by BGF. The Carmarthenshire-headquartered business is now poised for a period of accelerated grow...
09.11.2023BGF responds to Apax Partners LLP takeover offer for Kin & Carta PlcBGF, one of the largest dedicated investors to smaller companies in the UK, responds to Apax Partners LLP takeover offer for Kin & Carta Plc (“Kin & Carta“). BGF, as a holder of approximately 3.0% of Kin & Carta’s share capital...
09.11.2023BGF hits ‘Purple’ patch with £10.5 million investmentThe WiFi and location analytics platform Purple, based in the North West, has announced a £10.5 million investment from BGF. Purple was founded in 2012 by Gavin Wheeldon, out of frustration for poor guest Wi-Fi connections, and has now evo...
27.10.2023Aligning values and public purpose: in conversation with Socitm AdvisoryWhich areas of ESG should we be prioritising as a business? What does purpose really mean for our bottom line? How can we engage internal and external stakeholders in our ESG agenda? These are just some of the questions that BGF’s head of E...
26.10.2023BGF expands Reading team with appointment of investor Harry KernickBGF has appointed Harry Kernick to its investment team in Reading. Harry will play a key role in supporting the growth potential of ambitious businesses across the Thames Valley and Solent regions. He will be responsible for all aspects of ...
16.10.2023Green innovator Artus Air secures significant investment to drive growthBGF has completed a multi-million-pound investment into Artus Air Limited, as part of a wider funding round alongside leading venture capital firm Par Equity. Artus designs and sells game-changing HVAC (heating, ventilation, and air condit...
Show more

Mentions in press and media 332

DateTitleDescription
01.04.2025Phlux Technology: Igniting the Future of Infrared SensingIn the heart of Sheffield, a technological revolution is brewing. Phlux Technology, an infrared sensor startup, has just secured €10.7 million in a Series A funding round. This infusion of capital is not just a financial boost; it’s a catal...
31.03.2025Phlux Technology bags over €10 million for their infrared sensor technologyPhlux Technology, a Sheffield-based infrared sensor startup, has raised €10.7 million in a Series A funding round to enable the next generation of fibre broadband connectivity and expand into the optical communications and sensing markets. ...
18.03.2025Maxion Therapeutics: A New Dawn in Biotech InnovationIn the heart of Cambridge, a biotech revolution is brewing. Maxion Therapeutics has just secured €68.9 million in a Series A funding round, marking a significant milestone in the quest for innovative therapies. This funding, led by General ...
18.03.2025Maxion Therapeutics: £58 Million (Series A) Closed For Developing KnotBody Drugs For Ion Channel- And GPCR-Driven DiseasesMaxion Therapeutics, a biotechnology company developing antibody-based KnotBody drugs for ion channel- and G protein-coupled receptor (GPCR)-driven diseases, announced that it has raised $72 million (£58 million) in a Series A financing. Th...
17.03.2025Maxion Therapeutics raises €68 million to advance its KnotBody pipeline and platformCambridge-based Maxion Therapeutics, a BioTech company developing antibody-based KnotBody drugs for ion channel and G protein coupled receptor (GPCR) driven diseases, announced today that it has raised €68.9 million in a Series A financing....
17.03.2025Maxion Therapeutics Raises $72M in Series A FundingMaxion Therapeutics, a Cambridge, UK-based biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, raised $72M (£58M) in Series A funding. The round was led by ...
17.03.2025Biotech Maxion Therapeutics secures $72M Series ACambridge-based Maxion Therapeutics, a biotech developing antibody-based drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised $72M in a Series A round. The round was led by General Catalyst with additiona...
24.02.2025OrganOx Closes $142M Equity FinancingOrganOx, an Oxford, UK-based organ medical technology company, raised $142M in equity funding. The round was led by new investor HealthQuest Capital with participation from existing investors BGF and Lauxera Capital Partners, along with add...
24.02.2025Cambridge GaN Devices: $32 Million (Series C) Raised For Energy-Efficient SemiconductorsCambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, announced it closed a $32 million Series C funding round. The funding round was led by a strategic investor with participation from British Patient Capital an...
19.02.2025Cambridge GaN Devices Secures $32M to Power Global ExpansionIn a world racing towards energy efficiency, Cambridge GaN Devices (CGD) has emerged as a beacon of innovation. The UK-based company recently secured $32 million in Series C funding, a financial boost that promises to accelerate its growth ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In